XASE:CRMD Cormedix Inc Insider Activity 4 Filing - 9/20/2012

Effective Date 9/20/2012

XASE:CRMD (Cormedix Inc): Fair Value Estimate
Premium
XASE:CRMD (Cormedix Inc): Consider Buying
Premium
XASE:CRMD (Cormedix Inc): Consider Selling
Premium
XASE:CRMD (Cormedix Inc): Fair Value Uncertainty
Premium
XASE:CRMD (Cormedix Inc): Economic Moat
Premium
XASE:CRMD (Cormedix Inc): Stewardship
Premium
 
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Lefkowitz Steven W
  2. Issuer Name and Ticker or Trading Symbol
CorMedix Inc. [CRMD]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
C/O CORMEDIX INC., 745 RT. 202-206, SUITE 303
3. Date of Earliest Transaction (Month/Day/Year)
09/20/2012
(Street)

BRIDGEWATER, NJ 08807
4. If Amendment, Date Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Senior Convertible Note (convertible into Common Stock)(1) $0.35 09/20/2012   P   1   09/20/2012 09/20/2013 Common Stock, $0.001 par value per share 100,000 (1) 1 I I(1)
Warrant (right to purchase Common Stock)(1) $0.4 09/20/2012   P   1   09/20/2012 09/20/2017 Common Stock, $0.001 par value per share 87,500 (1) 1 I I(1)
Senior Convertible Note (convertible into Common Stock)(1) $0.35 09/20/2012   P   1   09/20/2012 09/20/2013 Common Stock, $0.001 par value per share 42,857 (2) 1 D  
Warrant (right to purchase Common Stock)(1) $0.4 09/20/2012   P   1   09/20/2012 09/20/2017 Common Stock, $0.001 par value per share 37,500 (2) 1 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Lefkowitz Steven W
C/O CORMEDIX INC.
745 RT. 202-206, SUITE 303
BRIDGEWATER, NJ 08807
  X      

Signatures

 /s/ Steven W. Lefkowitz   09/24/2012
** Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) On September 20, 2012, the reporting person acquired, indirectly through Wade Capital Corporation (an entity for which he has voting and investment control) in a private placement $35,000 of (i) 9% Senior Convertible Notes, convertible into shares of the Company's Common Stock, $0.001 par value per share, at a conversion price of $0.35 per share; and (ii) a five-year redeemable warrant to purchase common stock at an exercise price of $0.40 per share.
(2) On September 20, 2012, the reporting person acquired directly ) in a private placement $15,000 of (i) 9% Senior Convertible Notes, convertible into shares of the Company's Common Stock at a conversion price of $0.35 per share; and (ii) a five-year redeemable warrant to purchase common stock at an exercise price of $0.40 per share.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

XASE:CRMD Cormedix Inc Insider Activity 4 Filling

Cormedix Inc XASE:CRMD Stock - Get Insider Activity SEC Filing of Cormedix Inc XASE:CRMD stocks, including company profile, shares outstanding, strategy, business segments, operations, officers, consolidated financial statements, financial notes and ownership information.

XASE:CRMD Cormedix Inc Insider Activity 4 Filing - 9/20/2012
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Title |  Date |  Company |  Symbol |  Interest |  Popularity

Previous: XASE:CRMD Cormedix Inc Insider Activity 4 Filing - 9/20/2012  |  Next: XASE:CRMD Cormedix Inc Insider Activity 4/A Filing - 9/20/2012